Buying a Licensed Pharmaceutical Wholesaler in Kenya

Buying a licensed pharmaceutical wholesaler in Kenya looks like a shortcut. The target already has a warehouse, a superintendent pharmacist, a customer book and, in theory, the Pharmacy and Poisons Board (PPB) approvals that take months to obtain from scratch. In practice, those approvals are tied to the holder, the premises and the people running the business, and several of them do not survive a change of ownership intact. This guide explains what a buyer is really acquiring, which approvals are at risk, and how to structure the deal so that the business can keep trading on completion.

What the Licences Actually Attach To

A pharmaceutical wholesaler typically depends on four sets of approvals, each with its own rules:

• The wholesale dealer’s licence under section 27 of the Pharmacy and Poisons Act (Cap. 244). It is issued per set of premises, expires every 31 December, and can only be issued or renewed if the business has a registered pharmacist resident in Kenya in control of distribution. The Board may revoke it for any good and sufficient reason relating to the licensee or its premises.
• Premises registration under section 23. Under section 23(3), registration becomes void thirty days after any change in the ownership of the business carried on in the premises.
• The company’s right to trade under section 21, which depends on having a superintendent who is a registered pharmacist, a director, and not superintendent of any other company.
• Product registrations under the Pharmacy and Poisons (Registration of Health Products and Technologies) Rules, 2022. These usually belong to the foreign manufacturers, with the wholesaler acting as their local representative under rule 4(2)(b), not to the wholesaler itself.

If the target handles narcotic drugs or psychotropic substances, it will also hold authority under the Narcotic Drugs and Psychotropic Substances (Control) Act (Cap. 245). Section 16 of that Act vests licensing in a dedicated Board, and dealing outside a valid licence falls within the Act’s definition of trafficking.

Share Purchase or Asset Purchase

The structure of the deal decides which approvals are disturbed.

An asset purchase moves the business into a new owner. The licence, which was issued to the seller, does not travel with the stock and the lease. The buyer needs its own wholesale licence and premises registration, and the section 23(3) thirty-day clock is triggered. Without careful sequencing, there will be a gap in which the buyer owns the business but cannot lawfully trade.

A share purchase leaves the licensed company in place, so the licence holder does not change. That is usually the better route, but it is not a clean pass. Whether a change in the shareholders amounts to a “change in the ownership of the business” for section 23(3) is a question the Act does not answer clearly. The prudent course is to engage the PPB before completion and agree how it will treat the transaction, rather than to rely on an argument after the event. A share deal also means the buyer inherits the company’s history, including any past breaches.

Due Diligence That Matters Most

General corporate due diligence is covered in our guide to M&A due diligence in Kenya’s healthcare sector. For a wholesaler, the regulatory items carry the most risk:

• Licence status per premises. Confirm a current licence for every warehouse and depot, not just the head office, and check the register the Registrar keeps under section 27(6).
• The superintendent. Confirm the pharmacist is genuinely employed, actually manages the business, is resident in Kenya, and is not superintendent elsewhere. A nominal superintendent is a red flag for the whole business. See our guide to name-lending pharmacists.
• Inspection and enforcement history. Ask for PPB inspection reports, closure notices, product seizures and any correspondence about breaches.
• Controlled substances. If the target deals in them, reconcile registers against stock and import authorisations. Unexplained gaps are not just a valuation issue; they may be evidence of diversion.
• Distribution agreements. Check whether the target’s supply and local representation agreements with manufacturers have change-of-control clauses that let the principal terminate.

Structuring the Transaction

Several contractual protections are worth insisting on:

• Regulatory conditions precedent. Make completion conditional on written PPB confirmation of how the licences and premises registrations will be treated, and on Competition Authority clearance where the merger thresholds are met.
• Superintendent continuity. Secure a new service agreement with the incumbent superintendent, or a qualified replacement, signed before completion and taking effect on it.
• Specific indemnities. Seek specific indemnities for pre-completion regulatory breaches. General warranties are often too weak where a breach can lead to licence revocation.
• Retention. Hold back part of the price until renewals for the next licensing year are granted.

When Building Is Better Than Buying

For a foreign investor, acquisition is not always faster. If the target’s compliance history is weak, the superintendent arrangement is doubtful, or the licences would need to be re-issued anyway, incorporating a new company and applying for fresh approvals may carry less risk. Our guide to obtaining a pharmaceutical wholesale licence in Kenya sets out that route.

Frequently asked questions

This article is general information on Kenyan law as at its publication date, not legal advice. Reading it does not create an advocate and client relationship.